GC Therapeutics
Kathryn Swiderski has accumulated a wealth of experience in various roles related to operations, marketing, and sales. With a background in Economics & Philosophy from Boston College, Kathryn has held positions at companies such as GC Therapeutics, Paros Bio, and Semma Therapeutics. Beginning their career as an International Teacher at Harvard University Center for International Development, Kathryn has since transitioned into roles of increasing responsibility in the operations field.
This person is not in any teams
GC Therapeutics
1 followers
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.